Vaccination against respiratory syncytial virus: problems and progress.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  FEMS Microbiology Immunology

• Publication date

  1991-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.1574-6968.1991.TB04221.XPMID 1797047
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of synthetic peptides to locate neutralizing antigenic domains on the fusion protein of respiratory syncytial virus.

  1991cited by this paper
• Recognition of respiratory syncytial (RS) virus proteins by human and BALB/C CD4+ lymphocytes

  1991cited by this paper
• Comparison of the virulence of wild-type thymidine kinase (tk)-deficient and tk+ phenotypes of vaccinia virus recombinants after intranasal inoculation of mice.

  1991cited by this paper
• Evaluation in chimpanzees of vaccinia virus recombinants that express the surface glycoproteins of human respiratory syncytial virus.

  1990cited by this paper
• The 22,000-kilodalton protein of respiratory syncytial virus is a major target for Kd-restricted cytotoxic T lymphocytes from mice primed by infection

  1990cited by this paper
• Identification of a linear epitope on the fusion glycoprotein of respiratory syncytial virus.

  1990cited by this paper
• The small hydrophobic protein of human respiratory syncytial virus: comparison between antigenic subgroups A and B.

  1990cited by this paper
• Immunoprophylaxis of infections with respiratory syncytial virus: observations and hypothesis.

  1990cited by this paper
• Location of a highly conserved neutralizing epitope in the F glycoprotein of human respiratory syncytial virus

  1990cited by this paper
• Synthetic immunogens constructed from T-cell and B-cell stimulating peptides (T:B chimeras): preferential stimulation of unique T- and B-cell specificities is influenced by immunogen configuration.

  1990cited by this paper
• Clinical and immunologic response of cattle to administration of a vaccine containing modified-live bovine respiratory syncytial virus.

  1990cited by this paper
• Immune response to experimentally induced infection with respiratory syncytial virus: possible role in the development of pulmonary disease.

  1989cited by this paper
• The 1B (NS2), 1C (NS1) and N proteins of human respiratory syncytial virus (RSV) of antigenic subgroups A and B: sequence conservation and divergence within RSV genomic RNA.

  1989cited by this paper
• Prostaglandin and thromboxane concentrations in plasma and lung lavage fluids during sequential infection of vaccinated and nonvaccinated calves with bovine respiratory syncytial virus.

  1989cited by this paper
• Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins

  1989cited by this paper
• Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease.

  1989cited by this paper
• Comparative virulence of respiratory syncytial virus subgroups A and B.

  1989cited by this paper
• Ischemia Alters Cerebral Vascular Responses to Hypercapnia and Acetylcholine in Piglets

  1989cited by this paper
• Development of cell‐mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection

  1989cited by this paper
• Immunosuppression of the antibody response to respiratory syncytial virus (RSV) by pre-existing serum antibodies: partial prevention by topical infection of the respiratory tract with vaccinia virus-RSV recombinants.

  1989cited by this paper
• Mechanism of lung injury in cotton rats immunized with formalin-inactivated respiratory syncytial virus.

  1989cited by this paper
• Comparison of antigenic sites of subtype-specific respiratory syncytial virus attachment proteins.

  1989cited by this paper
• Processing, surface expression, and immunogenicity of carboxy-terminally truncated mutants of G protein of human respiratory syncytial virus

  1989cited by this paper
• Antibody-mediated enhancement of respiratory syncytial virus infection in two monocyte/macrophage cell lines.

  1989cited by this paper
• Detection of IgE antibodies to bovine respiratory syncytial virus.

  1989cited by this paper
• In vitro enhancement of respiratory syncytial virus infection of U937 cells by human sera.

  1989cited by this paper
• IgG and IgM antibodies to viral glycoproteins in respiratory syncytial virus infections of graded severity.

  1989cited by this paper
• Respiratory syncytial virus pneumonia in a human immunodeficiency virus-infected man.

  1989cited by this paper
• Effect of vaccination on cell populations in lung washes from calves after infection with respiratory syncytial virus.

  1989cited by this paper
• A 16-amino acid peptide of respiratory syncytial virus 1A protein contains two overlapping T cell-stimulating sites distinguishable by class II MHC restriction elements.

  1989cited by this paper
• Rapid Screening Tests for HIV

  1989cited by this paper
• Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function

  1989cited by this paper
• A severe outbreak of respiratory tract disease associated with bovine respiratory syncytial virus probably enhanced by vaccination with modified live vaccine.

  1989cited by this paper
• Respiratory syncytial virus infection in children with bronchopulmonary dysplasia.

  1988cited by this paper
• Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus

  1988cited by this paper
• The purification of four respiratory syncytial virus proteins and their evaluation as protective agents against experimental infection in BALB/c mice.

  1988cited by this paper
• Helper T cell recognition of respiratory syncytial virus in mice.

  1988cited by this paper
• Respiratory syncytial virus infection in immunocompromised adults.

  1988cited by this paper
• Respiratory syncytial virus epidemics: variable dominance of subgroups A and B strains among children, 1981-1986.

  1988cited by this paper
• Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus.

  1988cited by this paper
• Respiratory Syncytial Virus

  1988cited by this paper
• Evaluation in non-human primates of the safety, immunogenicity and efficacy of recombinant vaccinia viruses expressing the F or G glycoprotein of respiratory syncytial virus.

  1988cited by this paper
• Mapping an antibody-binding site and a T-cell-stimulating site on the 1A protein of respiratory syncytial virus

  1988cited by this paper
• Occurrence of respiratory syncytial virus subgroup A and B strains in Japan, 1980 to 1987

  1988cited by this paper
• Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses

  1988cited by this paper
• Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity

  1988cited by this paper
• Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity

  1987cited by this paper
• Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis.

  1987cited by this paper
• Lymphocyte transformation response of calves to respiratory syncytial virus

  1987cited by this paper
• Subgroup characteristics of respiratory syncytial virus strains recovered from children with two consecutive infections

  1987cited by this paper
• Preparation and characterization of monoclonal antibodies directed against five structural components of human respiratory syncytial virus subgroup B.

  1987cited by this paper
• Mammary immunity in mothers of infants with respiratory syncytial virus infection

  1987cited by this paper
• Identification of a synthetic peptide as part of a major neutralization epitope of respiratory syncytial virus.

  1987cited by this paper
• Monoclonal antibodies demonstrate heterogeneity in the G glycoprotein of prototype strains and clinical isolates of respiratory syncytial virus

  1987cited by this paper
• Site-directed serology with synthetic peptides representing the large glycoprotein G of respiratory syncytial virus.

  1987cited by this paper
• Relation of Serum Antibody to Glycoproteins of Respiratory Syncytial Virus with Immunity to Infection in Children

  1987cited by this paper
• The Biology of negative strand viruses

  1987cited by this paper
• Respiratory syncytial virus fusion glycoprotein: further characterization of a major epitope involved in virus neutralization.

  1987cited by this paper
• Clearance of persistent respiratory syncytial virus infections in immunodeficient mice following transfer of primed T cells.

  1987cited by this paper
• Virus-specific IgE and IgG4 antibodies in serum of children infected with respiratory syncytial virus.

  1987cited by this paper
• Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus

  1987cited by this paper
• Strain variation of respiratory syncytial virus.

  1987cited by this paper
• Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children

  1987cited by this paper
• The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins.

  1987cited by this paper
• Local and systemic antibody response to bovine respiratory syncytial virus infection and reinfection in calves with and without maternal antibodies

  1987cited by this paper
• Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine

  1986cited by this paper
• Passively acquired antibodies to respiratory syncytial virus impair the secondary cytotoxic T-cell response in the neonatal mouse.

  1986cited by this paper
• Respiratory syncytial viral infection in children with compromised immune function.

  1986cited by this paper
• Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection

  1986cited by this paper
• Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus

  1986cited by this paper
• Seasonal Variations in Maternal Serum and Mammary Immunity to RS Virus

  1986cited by this paper
• Occurrence of respiratory syncytial virus subtypes a and b strains in sweden

  1986cited by this paper
• Analysis of the respiratory syncytial virus fusion protein using monoclonal and polyclonal antibodies.

  1986cited by this paper
• Antigenic variation between human respiratory syncytial virus isolates.

  1986cited by this paper
• Murine cytotoxic T cells specific to respiratory syncytial virus recognize different antigenic subtypes of the virus.

  1986cited by this paper
• Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity.

  1986cited by this paper
• Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants.

  1986cited by this paper
• Expression of the major glycoprotein G of human respiratory syncytial virus from recombinant vaccinia virus vectors.

  1986cited by this paper
• Risk of primary infection and reinfection with respiratory syncytial virus.

  1986cited by this paper
• Concurrent circulation of antigenically distinct strains of respiratory syncytial virus during community outbreaks.

  1986cited by this paper
• Specific human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virus.

  1986cited by this paper
• Structural differences between subtype A and B strains of respiratory syncytial virus.

  1986cited by this paper
• Antigenic analysis of a putative new strain of respiratory syncytial virus.

  1985cited by this paper
• Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat.

  1985cited by this paper
• Respiratory syncytial virus. Brief review.

  1985cited by this paper
• Cytotoxic T-cell response to respiratory syncytial virus in mice

  1985cited by this paper
• Two distinct subtypes of human respiratory syncytial virus.

  1985cited by this paper
• Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies.

  1985cited by this paper
• Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model.

  1985cited by this paper
• Antigenic and structural variation in the major nucleocapsid protein of respiratory syncytial virus.

  1984cited by this paper
• Monoclonal antibodies protect against respiratory syncytial virus infection in mice.

  1984cited by this paper
• Respiratory viruses and sudden infant death.

  1984cited by this paper
• Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies

  1984cited by this paper
• Monoclonal antibodies to human respiratory syncytial virus and their use in comparison of different virus isolates.

  1984cited by this paper
• Respiratory syncytial virus infection in the elderly 1976-82.

  1983cited by this paper
• Cellular and Humoral Immunity in Recurrent Respiratory Syncytial Virus Infections

  1983cited by this paper
• Respiratory syncytial viral infection in infants with congenital heart disease.

  1982cited by this paper
• Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial.

  1982cited by this paper
• The role of respiratory syncytial virus and other viral pathogens in acute otitis media.

  1982cited by this paper
• Maternal antibody and respiratory syncytial virus infection in infancy

  1981cited by this paper

• Complete Genome Sequences of Sequence Type 71 (ST71) and ST97 Staphylococcus aureus Isolates from Bovine Milk

  2018cites this paper
• Staphylococcal Plasmids, Transposable and Integrative Elements

  2018cites this paper
• Replication of Staphylococcal Resistance Plasmids

  2017cites this paper
• Two highly divergent lineages of exfoliative toxin B-encoding plasmids revealed in impetigo strains of Staphylococcus aureus.

  2017cites this paper
• ARCHIVES OF DISEASE IN CHILDHOOD

  2006cites this paper
• Conjugation in Gram-Positive Bacteria

  2004cites this paper
• Epidemiology of respiratory syncytial virus infection among paediatric patients in Hong Kong: seasonality and disease impact

  1999cites this paper
• Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus

  1996cites this paper
• Surface display on staphylococci: a comparative study

  1996cites this paper
• Identification of mutations contributing to the reduced virulence of a modified strain of respiratory syncytial virus.

  1996cites this paper
• Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in Balb/c mice that are similar to those generated by experimental infection.

  1995cites this paper
• Respiratory syncytial virus--how soon will we have a vaccine?

  1995cites this paper
• Hydrophobicity engineering to increase solubility and stability of a recombinant protein from respiratory syncytial virus.

  1995cites this paper
• Hydrophobicity engineering to facilitate surface display of heterologous gene products on Staphylococcus xylosus.

  1995cites this paper
• Development of Subunit Paramyxoviridae Vaccines

  1994cites this paper
• The pulmonary immune response of Balb/c mice vaccinated with the fusion protein of respiratory syncytial virus.

  1994cites this paper
• Respiratory syncytial virus

  1993cites this paper
• Binding of neutralizing monoclonal antibodies to regions of the fusion protein of respiratory syncytial virus expressed in Escherichia coli.

  1993cites this paper